Search

Your search keyword '"Yang, J.C."' showing total 8 results
Start Over Author "Yang, J.C." Topic cancer chemotherapy
8 results on '"Yang, J.C."'

1. 6P Pembrolizumab plus chemotherapy vs chemotherapy in Asian patients with PD-L1 negative advanced NSCLC: Pooled analysis of KN021G, KN189 and KN407.

Author

Cheng, Y., Yang, J.C-H., Okamoto, I., Zhang, L., Hu, J., Wang, D., Hu, C., Zhou, J., Wu, L., Cao, L., Liu, J., Zhang, H., Sun, H., Wang, Z., Gao, H., Yan, Y., Xiao, S., Lin, J., Pietanza, M.C., and Kurata, T.

Subjects
*ASIANS, *PROGRAMMED death-ligand 1, *CANCER chemotherapy, *NON-small-cell lung carcinoma, *PEMBROLIZUMAB
Published
2021
Full Text
View/download PDF

4. 1507TiP Phase Ib multicenter study of trastuzumab deruxtecan (T-DXd) and immunotherapy with or without chemotherapy in first-line treatment of patients (pts) with advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) and HER2 overexpression (OE): DESTINY-Lung03

Author

Planchard, D., Brahmer, J.R., Yang, J.C-H., Kim, H.R., Li, R.K., Han, J-Y., Cortinovis, D.L., Runglodvatana, Y., Nakajima, E., Ragone, A., Winter, M., and Gustavson, M.

Subjects
*NON-small-cell lung carcinoma, *TRASTUZUMAB, *IMMUNOTHERAPY, *CANCER chemotherapy, *METASTASIS
Published
2023
Full Text
View/download PDF

6. 514MO Acquired mechanisms of resistance to first-line (1L) osimertinib with or without platinum-based chemotherapy (CT) in EGFR-mutated (EGFRm) advanced NSCLC: Preliminary data from FLAURA2.

Author

Lee, C.K., Robichaux, J.P., Jänne, P.A., Kim, S-W., Kim, T.M., Kobayashi, K., Planchard, D., Sugawara, S., Yanagitani, N., Yang, T-Y., Markovets, A., Bhetaryia, P., Poole, L., Rukazenkov, Y., Hartmaier, R.J., and Yang, J.C-H.

Subjects
*OSIMERTINIB, *NON-small-cell lung carcinoma, *CANCER chemotherapy
Published
2023
Full Text
View/download PDF

7. 512MO FLAURA2: Safety and CNS outcomes of first-line (1L) osimertinib (osi) ± chemotherapy (CTx) in EGFRm advanced NSCLC.

Author

Planchard, D., Jänne, P.A., Cheng, Y., Lee, C.K., Laktionov, K., Yang, T-Y., Yu, Y., Kato, T., Jiang, L., Chewaskulyong, B., Lucien Geater, S., Maurel, J-M., Rojas, C., Havel, L., Shepherd, F.A., Tanaka, K., Ghiorghiu, D., Armenteros Monterroso, E., Huang, X., and Yang, J.C-H.

Subjects
*OSIMERTINIB, *NON-small-cell lung carcinoma, *CANCER chemotherapy, *SAFETY
Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results